Increased B cell and cytotoxic NK cell proportions and increased T cell responsiveness in blood of natalizumab-treated multiple sclerosis patients. Mellergård J, Edström M, Jenmalm MC, Dahle C, Vrethem M, Ernerudh J PLoS One. 2013; 8(12):e81685. Epub 2013 Dec 02. PMID: 24312575. Abstract CommentRecommendBookmarkWatch